This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: AI Speech Co., Ltd., Suzhou Raymon Pharmaceuticals Company, Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 3 Years Active: 2025-2026
Title: Sen Wang: Innovator in Medicinal Chemistry
Introduction
Sen Wang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic use. His work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Sen Wang holds a patent for the use of a naphthylurea compound. This invention provides a method for preparing a medicament aimed at treating corneal neovascular disease. The naphthylurea compound, as described in his patent, can be administered through eye drops, offering a targeted approach to treatment.
Career Highlights
Sen Wang is associated with Suzhou Raymon Pharmaceuticals Company, Ltd., where he continues to advance his research and development efforts. His expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Sen Wang collaborates with Fei Zhang, enhancing the research capabilities within their team. Their combined efforts contribute to the innovative projects at their company.
Conclusion
Sen Wang's work exemplifies the impact of innovative research in the pharmaceutical field. His contributions to medicinal chemistry are paving the way for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile